Peggy M Cawthon1, Thomas G Travison2, Todd M Manini3, Sheena Patel1, Karol M Pencina4, Roger A Fielding5, Jay M Magaziner6, Anne B Newman7, Todd Brown8, Douglas P Kiel2,9, Steve R Cummings1, Michelle Shardell9, Jack M Guralnik6, Linda J Woodhouse10, Marco Pahor3, Ellen Binder11, Ralph B D'Agostino12, Xue Quian-Li13, Eric Orwoll14, Francesco Landi15, Denise Orwig6, Laura Schaap16, Nancy K Latham4, Vasant Hirani17, Timothy Kwok18,19, Suzette L Pereira20, Daniel Rooks21, Makoto Kashiwa22, Moises Torres-Gonzalez23, Joseph P Menetski24, Rosaly Correa-De-Araujo25, Shalender Bhasin4. 1. California Pacific Medical Center Research Institute, San Francisco Coordinating Center, California. 2. Department of Medicine, Marcus Institute for Aging Research, Hebrew SeniorLife, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts. 3. University of Florida, Gainesville. 4. Boston Claude D. Pepper Older Americans Independence Center, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. 5. Nutrition, Exercise Physiology and Sarcopenia Laboratory, Jean Mayer U.S. Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts. 6. Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore. 7. Department of Epidemiology, University of Pittsburgh, Pennsylvania. 8. Division of Endocrinology, Diabetes, and Metabolism, Johns Hopkins University, Baltimore, Maryland. 9. Longitudinal Studies Section, The National Institute on Aging, Baltimore, Maryland. 10. Faculty of Rehabilitation Medicine, University of Alberta, Edmonton, Canada. 11. Division of Geriatrics, Washington University School of Medicine, St Louis, Missouri. 12. Department of Mathematics, Framingham Heart Study, Boston University, Massachusetts. 13. Director of Biostatistics, Division of Geriatric Medicine and Gerontology and Center on Aging and Health, Johns Hopkins Medical Institute, Baltimore, Maryland. 14. Division of Endocrinology, Metabolism and Clinical Nutrition, Oregon Health and Sciences University, Portland. 15. Department of Medicine and Geriatrics, Catholic University of Sacred Heart, Rome, Italy. 16. Faculty of Science, Nutrition and Health Aging and Later Life, Free University of Amsterdam, The Netherlands. 17. School of Life and Environmental Sciences, University of Sydney, Australia. 18. Department of Medicine and Therapeutics, Faculty of Medicine. 19. School of Public Health, The Chinese University of Hong Kong, China. 20. Abbott Nutrition, Abbott Laboratories, Chicago, Illinois. 21. Novartis Biomedical Research Institute, Cambridge, Massachusetts. 22. Astellas Pharma Inc., Tokyo, Japan. 23. National Dairy Council, Rosemont, Illinois. 24. The Foundation for the National Institutes of Health, Bethesda, Maryland. 25. The National Institute on Aging, Bethesda, Maryland.
Abstract
BACKGROUND: Lack of consensus on how to diagnose sarcopenia has limited the ability to diagnose this condition and hindered drug development. The Sarcopenia Definitions and Outcomes Consortium (SDOC) was formed to develop evidence-based diagnostic cut points for lean mass and/or muscle strength that identify people at increased risk of mobility disability. We describe here the proceedings of a meeting of SDOC and other experts to discuss strategic considerations in the development of evidence-based sarcopenia definition. METHODS: Presentations and panel discussions reviewed the usefulness of sarcopenia as a biomarker, the analytical approach used by SDOC to establish cut points, and preliminary findings, and provided strategic direction to develop an evidence-based definition of sarcopenia. RESULTS: The SDOC assembled data from eight epidemiological cohorts consisting of 18,831 participants, clinical populations from 10 randomized trials and observational studies, and 2 nationally representative cohorts. In preliminary assessments, grip strength or grip strength divided by body mass index was identified as discriminators of risk for mobility disability (walking speed <0.8 m/s), whereas dual-energy X-ray absorptiometry-derived lean mass measures were not good discriminators of mobility disability. Candidate definitions based on grip strength variables were associated with increased risk of mortality, falls, mobility disability, and instrumental activities of daily living disability. The prevalence of low grip strength increased with age. The attendees recommended the establishment of an International Expert Panel to review a series of position statements on sarcopenia definition that are informed by the findings of the SDOC analyses and synthesis of literature. CONCLUSIONS: International consensus on an evidence-based definition of sarcopenia is needed. Grip strength-absolute or adjusted for body mass index-is an important discriminator of mobility disability and other endpoints. Additional research is needed to develop a predictive risk model that takes into account sarcopenia components as well as age, sex, race, and comorbidities.
BACKGROUND: Lack of consensus on how to diagnose sarcopenia has limited the ability to diagnose this condition and hindered drug development. The Sarcopenia Definitions and Outcomes Consortium (SDOC) was formed to develop evidence-based diagnostic cut points for lean mass and/or muscle strength that identify people at increased risk of mobility disability. We describe here the proceedings of a meeting of SDOC and other experts to discuss strategic considerations in the development of evidence-based sarcopenia definition. METHODS: Presentations and panel discussions reviewed the usefulness of sarcopenia as a biomarker, the analytical approach used by SDOC to establish cut points, and preliminary findings, and provided strategic direction to develop an evidence-based definition of sarcopenia. RESULTS: The SDOC assembled data from eight epidemiological cohorts consisting of 18,831 participants, clinical populations from 10 randomized trials and observational studies, and 2 nationally representative cohorts. In preliminary assessments, grip strength or grip strength divided by body mass index was identified as discriminators of risk for mobility disability (walking speed <0.8 m/s), whereas dual-energy X-ray absorptiometry-derived lean mass measures were not good discriminators of mobility disability. Candidate definitions based on grip strength variables were associated with increased risk of mortality, falls, mobility disability, and instrumental activities of daily living disability. The prevalence of low grip strength increased with age. The attendees recommended the establishment of an International Expert Panel to review a series of position statements on sarcopenia definition that are informed by the findings of the SDOC analyses and synthesis of literature. CONCLUSIONS: International consensus on an evidence-based definition of sarcopenia is needed. Grip strength-absolute or adjusted for body mass index-is an important discriminator of mobility disability and other endpoints. Additional research is needed to develop a predictive risk model that takes into account sarcopenia components as well as age, sex, race, and comorbidities.
Authors: R N Baumgartner; K M Koehler; D Gallagher; L Romero; S B Heymsfield; R R Ross; P J Garry; R D Lindeman Journal: Am J Epidemiol Date: 1998-04-15 Impact factor: 4.897
Authors: Eric Orwoll; Janet Babich Blank; Elizabeth Barrett-Connor; Jane Cauley; Steven Cummings; Kristine Ensrud; Cora Lewis; Peggy M Cawthon; Robert Marcus; Lynn M Marshall; Joan McGowan; Kathy Phipps; Sherry Sherman; Marcia L Stefanick; Katie Stone Journal: Contemp Clin Trials Date: 2005-10 Impact factor: 2.226
Authors: W Jack Rejeski; Roger A Fielding; Steven N Blair; Jack M Guralnik; Thomas M Gill; Evan C Hadley; Abby C King; Stephen B Kritchevsky; Michael E Miller; Anne B Newman; Marco Pahor Journal: Contemp Clin Trials Date: 2005-04 Impact factor: 2.226
Authors: Alfonso J Cruz-Jentoft; Jean Pierre Baeyens; Jürgen M Bauer; Yves Boirie; Tommy Cederholm; Francesco Landi; Finbarr C Martin; Jean-Pierre Michel; Yves Rolland; Stéphane M Schneider; Eva Topinková; Maurits Vandewoude; Mauro Zamboni Journal: Age Ageing Date: 2010-04-13 Impact factor: 10.668
Authors: Peggy M Cawthon; Katherine W Peters; Michelle D Shardell; Robert R McLean; Thuy-Tien L Dam; Anne M Kenny; Maren S Fragala; Tamara B Harris; Douglas P Kiel; Jack M Guralnik; Luigi Ferrucci; Stephen B Kritchevsky; Maria T Vassileva; Stephanie A Studenski; Dawn E Alley Journal: J Gerontol A Biol Sci Med Sci Date: 2014-05 Impact factor: 6.053
Authors: Peggy M Cawthon; Todd Manini; Sheena M Patel; Anne Newman; Thomas Travison; Douglas P Kiel; Adam J Santanasto; Kristine E Ensrud; Qian-Li Xue; Michelle Shardell; Kate Duchowny; Kristine M Erlandson; Karol M Pencina; Roger A Fielding; Jay Magaziner; Timothy Kwok; Magnus Karlsson; Claes Ohlsson; Dan Mellström; Vasant Hirani; Eva Ribom; Rosaly Correa-de-Araujo; Shalender Bhasin Journal: J Am Geriatr Soc Date: 2020-07-07 Impact factor: 5.562
Authors: Leon Lenchik; Ryan Barnard; Robert D Boutin; Stephen B Kritchevsky; Haiying Chen; Josh Tan; Peggy M Cawthon; Ashley A Weaver; Fang-Chi Hsu Journal: J Gerontol A Biol Sci Med Sci Date: 2021-01-18 Impact factor: 6.053
Authors: Todd M Manini; Sheena M Patel; Anne B Newman; Thomas G Travison; Douglas P Kiel; Michelle D Shardell; Karol M Pencina; Kevin E Wilson; Thomas L Kelly; Joseph M Massaro; Roger A Fielding; Jay Magaziner; Rosaly Correa-de-Araujo; Timothy C Y Kwok; Vasant Hirani; Magnus K Karlsson; Ralph B DʼAgostino; Dan Mellström; Claes Ohlsson; Eva Ribom; Joanne M Jordan; Shalender Bhasin; Peggy M Cawthon Journal: J Am Geriatr Soc Date: 2020-07-07 Impact factor: 5.562
Authors: Jesse Zanker; Sheena Patel; Terri Blackwell; Kate Duchowny; Sharon Brennan-Olsen; Steven R Cummings; William J Evans; Eric S Orwoll; David Scott; Sara Vogrin; Jane A Cauley; Gustavo Duque; Peggy M Cawthon Journal: J Am Med Dir Assoc Date: 2020-05-04 Impact factor: 4.669
Authors: Samaneh Farsijani; Lingshu Xue; Robert M Boudreau; Adam J Santanasto; Stephen B Kritchevsky; Anne B Newman Journal: J Gerontol A Biol Sci Med Sci Date: 2021-11-15 Impact factor: 6.053
Authors: Ryan McGrath; Terri L Blackwell; Kristine E Ensrud; Brenda M Vincent; Peggy M Cawthon Journal: J Gerontol A Biol Sci Med Sci Date: 2021-08-13 Impact factor: 6.053
Authors: John A Batsis; Christian Haudenschild; Robert M Roth; Tyler L Gooding; Meredith N Roderka; Travis Masterson; John Brand; Matthew C Lohman; Todd A Mackenzie Journal: J Am Med Dir Assoc Date: 2020-10-21 Impact factor: 4.669